Docetaxel 100 versus 80 mg/m2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial.
Bono
P
P
Kellokumpu-Lehtinen
P-L
PL
Alanko
T
T
Kokko
R
R
Asola
R
R
Turpeenniemi-Hujanen
T
T
Jyrkkiö
S
S
Kataja
V
V
Leinonen
M
M
Joensuu
H
H
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D000077143:Docetaxel; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D043823:Taxoids / Q000008:administration & dosage / Q000627:therapeutic use*
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel